Home › Cancer (all types) › Florida
Cancer (all types) clinical trials in Florida
130 studies for Cancer (all types) are looking for participants at sites in Florida.
Cities in Florida
- Tampa39 studies
- Miami36 studies
- Jacksonville30 studies
- Orlando25 studies
- Sarasota12 studies
- Gainesville9 studies
- Fort Lauderdale8 studies
- Plantation7 studies
- Cape Coral7 studies
- Deltona7 studies
- Hollywood6 studies
- Coral Springs6 studies
- Hialeah6 studies
- St. Petersburg5 studies
- Davie5 studies
- Boca Raton4 studies
- Kendall4 studies
- Miami Beach4 studies
- Deerfield Beach3 studies
- West Palm Beach3 studies
- Port Saint Lucie3 studies
Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carcinoma or Carcinosarcoma
- Broward Health Medical Center, Fort Lauderdale
- Sarasota Memorial Hospital-Venice, N. Venice
- AdventHealth Orlando, Orlando
- and 4 more
RecruitingPhase 3
Ages 18 and older · Women · Updated Sep 29, 2026 · NCT05256225Registry Study for Radiation Therapy Outcomes
- South Florida Proton Therapy Institute, Delray Beach
- Southwest Florida Proton Center, Fort Myers
- Ackerman Cancer Center, Jacksonville
- and 3 more
RecruitingObservational study
All ages · All sexes · Updated Sep 29, 2026 · NCT01255748A Study to Evaluate Adverse Events, Change in Disease Activity, Tolerability, and How Intravenous ABBV-438 Moves Through the Body in Adult Participants With Multiple Myeloma (MM)
- Moffitt Cancer Center /ID# 279068, Tampa
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 29, 2026 · NCT07409246REGN7508 in Adult Participants for Prevention of Cancer-Associated Thrombosis
- Bioresearch Partner- Hialeah Hospital, Hialeah
- Helios Clinical Research, North Miami Beach
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 29, 2026 · NCT07410117uTRACT Jelmyto Registry: A Registry of Patients With Upper Tract Urothelial Cancer (UTUC) Treated With Jelmyto
- University of Florida, Gainesville
- Mount Sinai Medical Center of Florida, Inc., Miami
- H. Lee Moffitt Cancer Center and Research Institute Hospital, Inc., Tampa
RecruitingObservational study
Ages 18 and older · All sexes · Updated Sep 29, 2026 · NCT05874921A Phase 1 Study of IM-1617 in Participants With Advanced Cancer
- Florida Cancer Specialists & Research Institute - Sarasota Cattlemen, Sarasota
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 29, 2026 · NCT07578571A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK) and Preliminary Clinical Activity of RO7673396 in Participants With Advanced Solid Tumors Harboring Rat Sarcoma Viral Oncogene Homolog (RAS) Mutation(s)
- Florida Cancer Specialists - Sarasota (North Catttlemen Rd), Sarasota
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT06884618Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
- Mayo Clinic Jacksonville, Jacksonville
- Moffitt Cancer Center, Tampa
RecruitingObservational study
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT04981119A Study of GSK5764227 in Combination With Standard of Care (SoC) or Other Agents in Participants With Advanced Solid Tumors
- GSK Investigational Site, Reunion
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT07277270A Study of JNJ-1761981 in Participants With Solid Tumors
- Mayo Clinic in Florida, Jacksonville
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT07525141A Study to Assess Adverse Events and Change in Disease Activity of Intravenous (IV) Telisotuzumab Adizutecan, Monotherapy or in Combination With Osimertinib, Compared to Standard of Care in Adult Participants With Locally Advanced or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer
- Cancer Specialists of North Florida /ID# 277332, Jacksonville
- Cancer Care Centers of Brevard- Rockledge /ID# 277853, Rockledge
- Moffitt Cancer Center /ID# 276785, Tampa
RecruitingPhase 2/3
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT07155187A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
- Mayo Clinic Pharmacy, Jacksonville
- Mayo Clinic, Jacksonville
RecruitingPhase 2/3
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT06989437A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)
- Boca Raton Clinical Research Coral Springs, Coral Springs
- Florida Clinical Trials Group Plantation, Plantation
- Florida Clinical Trials Group Tamarac, Tamarac
RecruitingPhase 3
Ages 18 to 100 · All sexes · Updated Sep 25, 2026 · NCT05920356Beginning Radiation Immediately With GammaTile at GBM Excision Versus Standard of Care
- Advent Health, Orlando
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT07195591A Study of MK-5684 in People With Certain Solid Tumors (MK-5684-015/OMAHA-015)
- Mount Sinai Cancer Center ( Site 0009), Miami Beach
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT06979596A Study of JNJ-88549968 for the Treatment of Calreticulin (CALR)-Mutated Myeloproliferative Neoplasms
- Moffit Cancer center, Tampa
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT06150157Multidisciplinary Intervention for Adults With Chronic Graft-versus-host Disease
- University of Miami Sylvester Comprehensive Cancer Center, Miami
Recruiting
Ages 18 and older · All sexes · Updated Sep 24, 2026 · NCT06910969A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer
- Florida Cancer Specialists & Research Institute - South /ID# 281387, Fort Myers
- Orlando Health Cancer Institute /ID# 280418, Orlando
- Moffitt Cancer Center /ID# 279732, Tampa
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 23, 2026 · NCT07365241Visugromab in Cachexia International Trial
- Clermont Oncology Center, Clermont
- Mid Florida Hematology and Oncology Centers, Orange City
- Cleveland Clinic Martin Health, Stuart
RecruitingPhase 2/3
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT07112196TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
- University of Miami/Sylvester Cancer Institute - Aventura, Aventura
- University of Miami/Sylvester Cancer Institute - Lennar, Coral Gables
- University of Miami/Sylvester Cancer Institute - Deerfield Beach, Deerfield Beach
- and 8 more
RecruitingPhase 2
Ages 12 and older · All sexes · Updated Sep 22, 2026 · NCT02693535Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
- Florida Cancer Specialists, Sarasota
- Moffitt Cancer Center and Research Institute, Tampa
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT06128551Prospective Study to Assess a Diagnostic Aid for Cancer
- Zoyla Almeida, MD PA, Coconut Creek
- BioResearch Partner, Hialeah
- Azzi ENT and Facial Reconstructive Surgery, Jupiter
- and 6 more
RecruitingObservational study
Ages 45 and older · All sexes · Updated Sep 21, 2026 · NCT07046260Generating Novel Translational and Therapeutic Strategies Based on a Multicenter, Pediatric and AYA Evolutionary Tumor Board (pedsETB)
- University of Miami, Miami
- Moffitt Cancer Center, Tampa
RecruitingObservational study
All ages · All sexes · Updated Sep 21, 2026 · NCT06423950Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
- The Mayo Clinic - Jacksonville, Davis-E, Jacksonville
- Sylvester Comprehensive Cancer Center, University of Miami Hospital and Clinics, Miami
- Baptist Cancer Center, Miami
- and 2 more
RecruitingPhase 2/3
All ages · All sexes · Updated Sep 18, 2026 · NCT03435796A Study of Patritumab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01C/LIGHTBEAM-U01)
- Johns Hopkins All Children's Hospital ( Site 3025), St. Petersburg
RecruitingPhase 1/2
1 Month – 17 Years · All sexes · Updated Sep 17, 2026 · NCT06941272Statins to Prevent Cancer Associated Blood Clots
- University of Miami, Miami
RecruitingPhase 4
Ages 18 and older · All sexes · Updated Sep 16, 2026 · NCT07303816Replacing Invasive Cystoscopy With Urine Testing for Non-muscle Invasive Bladder Cancer Surveillance
- Bay Pines VA Healthcare System, Bay Pines
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 16, 2026 · NCT05796375Met Non Small Cell Cancer Registry (MOMENT)
- Holy Cross Health, Fort Lauderdale
RecruitingObservational study
All ages · All sexes · Updated Sep 15, 2026 · NCT05376891Artificial Intelligence-Powered Support For Quality Of Life Improvement In Participants With Cancer
- Cleveland Clinic Florida, Weston
Recruiting
Ages 18 and older · All sexes · Updated Sep 15, 2026 · NCT07167056RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
- University of South Florida, Department of Psychiatry and Behavioral Neuroscience, Tampa
RecruitingPhase 2
Ages 18 to 80 · All sexes · Updated Sep 15, 2026 · NCT07002034A Study to Investigate Safety and Effectiveness of Tacabrutideg (BGB-16673) in Combination With Other Agents in Participants With Relapsed or Refractory B-Cell Malignancies
- Mayo Clinic Jacksonville, Jacksonville
- Moffitt Cancer Center, Tampa
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Sep 11, 2026 · NCT06634589A Study to Evaluate the Safety and Efficacy of MK-3120 in Participants With Advanced Solid Tumors (MK-3120-002)
- University of Miami Hospital and Clinics, Sylvester Cancer Center ( Site 1003), Miami
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Sep 10, 2026 · NCT06818643A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors
- Florida Cancer Specialist, Sarasota
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 9, 2026 · NCT06440005A Phase 1/1b Study of IAM1363 in HER2 Cancers
- University of Miami, Miami
- Comprehensive Hematology Oncology, St. Petersburg
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 9, 2026 · NCT06253871A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
- Millennium Oncology Research Clinic, Hollywood
- University of Florida - Jacksonville, Jacksonville
- Miami Cancer Institute at Baptist Health, Inc., Miami
- and 3 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 8, 2026 · NCT06119581A Study to Evaluate LY3537021 for the Treatment of Nausea and Vomiting Caused by Chemotherapy in Adults With Cancer
- Clavis Medical, Miami Lakes
- BRCR Global - Tamarac, Tamarac
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 4, 2026 · NCT07169851A Longitudinal Multi-Omic Biomarker Profiling Study of Patients With Head & Neck Squamous Cell Carcinoma (HNSCC)
- Mayo Clinic Florida, Jacksonville
RecruitingObservational study
Ages 18 and older · All sexes · Updated Sep 3, 2026 · NCT06163534Study of Sotorasib, Panitumumab and FOLFIRI Versus FOLFIRI With or Without Bevacizumab-awwb in Treatment-naïve Participants With Metastatic Colorectal Cancer With KRAS p.G12C Mutation
- Cancer Specialists of North Florida - Southpoint, Jacksonville
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 3, 2026 · NCT06252649Working Through Outreach, Navigation and Digital Enabled Referral and Recruitment Strategies (ACT WONDER²S)
- Moffitt Cancer Center, Tampa
RecruitingHealthy volunteers welcome
Ages 18 and older · All sexes · Updated Sep 3, 2026 · NCT06560398Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
- University of Miami _SCCC - Aventura, Aventura
- University of Miami-SCCC-Lennar, Coral Gables
- University of Miami_SCCC-Coral Springs, Coral Springs
- and 7 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 2, 2026 · NCT06072612From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.